JARED M KUSAR
Allopathic & Osteopathic Physicians|Internal Medicine AKRON, OH NPI 1720548993
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine OH Xeris Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$1,550.26
- Category: General Payments
- Program years: PY2022–2024
- Record count: 97
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $132.42 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $132.42 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | $21.84 | 1 |
| PFIZER INC. | $21.79 | 1 |
| Exact Sciences Corporation | $20.50 | 1 |
| Lilly USA, LLC | $19.94 | 1 |
| ABBVIE INC. | $18.86 | 1 |
| Amgen Inc. | $16.06 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.43 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1104121796 | ABBVIE INC. | $18.86 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111626083 | Amgen Inc. | $16.06 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1114744991 | Exact Sciences Corporation | $20.50 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118128877 | Boehringer Ingelheim Pharmaceuticals, Inc. | $13.43 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131444671 | PFIZER INC. | $21.79 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135028822 | Lilly USA, LLC | $19.94 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1144597848 | Xeris Pharmaceuticals, Inc. | $21.84 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.